Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-01

Clinical Trial Update: To Compare and Evaluate the Oral Bioavailability of Lisdexamfetamine 70 mg Capsule With That of Elvanse® 70 mg Capsules, Hard Lisdexamfetamine Dimesylate in Healthy, Adult, Human Subjects Under Fasting Conditions. [Phase 1]

View source ↗

Summary

A Phase 1 pharmacokinetic study comparing the oral bioavailability of lisdexamfetamine 70 mg capsules with Elvanse 70 mg capsules in healthy adult volunteers un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elvanse (lisdexamfetamine dimesylate)
  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

Sponsor: Humanis Saglık Anonim Sirketi | Conditions: Attention Deficit/Hyperactivity Disorder (ADHD) | Phase 1 | Status: COMPLETED